kdt-3594
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 26, 2017 (NCT03068481)
Timeline
Indications
Studied for
Mechanism of action
- Dopamine D1 receptorAGONIST
DRD1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- kdt-3594
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06722729 | Phase 2 | Dec 31, 2024 | Kissei Pharmaceuticals |
| NCT04867551 | Phase 2 | May 15, 2021 | Kissei Pharmaceuticals |
| NCT03845387 | Phase 2 | Feb 28, 2019 | Kissei Pharmaceuticals |
| NCT03068481 | Phase 1 | Feb 26, 2017 | Kissei Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kissei Pharmaceuticals | For profit | 4 | 4 | 2 | 2017 |
1 organizations
Page 1 / 1